Clinical trial
The Effect Of Pantoprazole 40 mg Once Daily Versus Placebo On The Power Spectral Analysis Of The Sleep Electroencephalogram (EEG) Of Patients With Gastroesophageal Reflux Disease (GERD)
NCT00674245 is registered in ClinicalTrials.gov with Southern Arizona VA Health Care System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect Of Pantoprazole 40 mg Once Daily Versus Placebo On The Power Spectral Analysis Of The Sleep Electroencephalogram (EEG) Of Patients With Gastroesophageal Reflux Disease (GERD)
- Lead sponsor
- Southern Arizona VA Health Care System
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- July 31, 2010
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastroesophageal reflux disease